Literature DB >> 11542188

Some acyclic analogues of nucleotides and their template-directed reactions.

M Tohidi1, L E Orgel.   

Abstract

Bismonophosphoimidazolides of acyclic analogues of guanosine IV and adenosine V were synthesized. They undergo oligomerization in the presence of complementary polynucleotide templates. Details of their synthesis and their subsequent template- and nontemplate-directed reactions are described, and their possible relevance to the origin of life is discussed.

Entities:  

Keywords:  NASA Discipline Exobiology; Non-NASA Center

Mesh:

Substances:

Year:  1989        PMID: 11542188     DOI: 10.1007/bf02603071

Source DB:  PubMed          Journal:  J Mol Evol        ISSN: 0022-2844            Impact factor:   2.395


  10 in total

1.  A simple one-step synthesis of ribonucleoside 2',3'-cyclic phosphate 5'-phosphates.

Authors:  A Simoncsits; J Tomasz
Journal:  Biochim Biophys Acta       Date:  1975-06-02

2.  Template-directed synthesis of novel, nucleic acid-like structures.

Authors:  A W Schwartz; L E Orgel
Journal:  Science       Date:  1985-05-03       Impact factor: 47.728

3.  The case for an ancestral genetic system involving simple analogues of the nucleotides.

Authors:  G F Joyce; A W Schwartz; S L Miller; L E Orgel
Journal:  Proc Natl Acad Sci U S A       Date:  1987-07       Impact factor: 11.205

4.  Template-directed synthesis of acyclic oligonucleotide analogues.

Authors:  J Visscher; A W Schwartz
Journal:  J Mol Evol       Date:  1988 Dec-1989 Feb       Impact factor: 2.395

5.  Origin of life: consideration of alternatives to proteins and nucleic acids.

Authors:  G L Nelsestuen
Journal:  J Mol Evol       Date:  1980-03       Impact factor: 2.395

6.  Synthesis and anti-herpes-virus activity of acyclic 2'-deoxyguanosine analogues related to 9-[(1,3-dihydroxy-2-propoxy)methyl]guanine.

Authors:  J C Martin; D P McGee; G A Jeffrey; D W Hobbs; D F Smee; T R Matthews; J P Verheyden
Journal:  J Med Chem       Date:  1986-08       Impact factor: 7.446

7.  Nucleic acid-like structures. II. Polynucleotide analogues as possible primitive precursors of nucleic acids.

Authors:  A W Schwartz; J Visscher; C G Bakker; J Niessen
Journal:  Orig Life Evol Biosph       Date:  1987       Impact factor: 1.950

8.  Synthesis and biological properties of 9-(trans-4-hydroxy-2-buten-1-yl)adenine and guanine: open-chain analogues of neplanocin A.

Authors:  S Phadtare; J Zemlicka
Journal:  J Med Chem       Date:  1987-02       Impact factor: 7.446

9.  9-[(1,3-Dihydroxy-2-propoxy)methyl]guanine: a new potent and selective antiherpes agent.

Authors:  J C Martin; C A Dvorak; D F Smee; T R Matthews; J P Verheyden
Journal:  J Med Chem       Date:  1983-05       Impact factor: 7.446

10.  Prebiotic synthesis of methionine.

Authors:  J E Van Trump; S L Miller
Journal:  Science       Date:  1972-11-24       Impact factor: 47.728

  10 in total
  6 in total

1.  Template-directed synthesis of oligonucleotides under eutectic conditions.

Authors:  R Stribling; S L Miller
Journal:  J Mol Evol       Date:  1991       Impact factor: 2.395

2.  Computer simulation in template-directed oligonucleotide synthesis.

Authors:  A Kanavarioti; C F Bernasconi
Journal:  J Mol Evol       Date:  1990-12       Impact factor: 2.395

3.  Polymerization of the cyclic pyrophosphates of nucleosides and their analogues.

Authors:  M Tohidi; L E Orgel
Journal:  J Mol Evol       Date:  1990       Impact factor: 2.395

4.  Template-directed oligomerization of 5'-deoxy-5'-nucleosideacetic acid derivatives.

Authors:  K Harada; L E Orgel
Journal:  Orig Life Evol Biosph       Date:  1990       Impact factor: 1.950

5.  Pyrophosphate formation as the most efficient condensation reaction of activated nucleotides.

Authors:  L Rodriguez; L E Orgel
Journal:  J Mol Evol       Date:  1991-02       Impact factor: 2.395

6.  Some biochemical properties of an acyclic oligonucleotide analogue. A plausible ancestor of the DNA?

Authors:  L Merle; G Spach; Y Merle; J Sági; A Szemzö
Journal:  Orig Life Evol Biosph       Date:  1993-04       Impact factor: 1.950

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.